Contribution of Lipoprotein(a) to polygenic risk of coronary artery disease: A prospective UK Biobank analysis

27 August 2023 (11:15 - 12:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Benoit Arsenault

Centre de Recherche de lInstitut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec (Canada)

6 More presentations in this session

Presentation thumbnail

HDLc levels have a protective effect for in-hospital mortality in Non-STEMI but not in STEMI patients.

Doctor A. Cordero (Alicante, ES)

Abstract Slides Video

Presentation thumbnail

The distribution of lipoprotein(a) in Norway: a nationwide population-based study

Ms J. Jeevanathan (Oslo, NO)

Abstract Slides Video

Presentation thumbnail

Real vs perceived LDL cholesterol control in clinical practice in Spain: Which factors are related to real control?

Doctor J. Cosin Sales (Valencia, ES)

Abstract Slides Video

Presentation thumbnail

Longitudinal trajectories of lipid parameters and their associations with mid-life carotid intima-media thickness

Mr A. Abdi (Tehran, IR)

Abstract Slides Video

Presentation thumbnail

Impact of ESC Guidelines implementation on lipid lowering strategy in a tertiary hospital cohort of STEMI patients: Can we aspire to do better than the EUROASPIRE V registry?

Doctor M. Ferrer (Barcelona, ES)

Abstract Slides Video

Access the full session

Session thumbnail

Risk factors and prevention: lipids (3)

The Event

Event poster

ESC Congress 2023

27 August 2023 11:15 CET

You may be interested in

Congress Presentation

Genetic scores are the future of personalised lipid-lowering

Congress Presentation

Polygenic risk scoring for coronary artery disease (CAD) - current data

Congress Presentation

Do genetic scores help risk stratify in primary prevention?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources